Kenneth A. Gall

Dr. Gall is currently the Associate Dean of Entrepreneurship and Professor of Mechanical Engineering and Materials Science at Duke University. His expertise is in the mechanical behavior of materials with emphasis on the creation, modification, understanding, and commercialization of synthetic biomaterials. His publications have been cited over 18,000 times with an H-index of 74. He is a founder and director of four medical device start-ups based on new biomaterials (MedShape, Vertera, Restor3d, and Lacuna) whose implants have been implanted in nearly 100,000 patients worldwide. He is also a Director in three other early stage medical device companies (DeepBlue, InnAVasc, and Kinos). MedShape is a fully functioning medical device company developing implants for foot and ankle reconstruction based on shape memory materials. MedShape’s sports medicine division was acquired by Conmed (NASDAQ:CNMD). Vertera created the first spinal fusion implants based on porous polymer technologies and was acquired by Nuvasive (NASDAQ:NUVA). Restor3d is utilizing 3D printing of polymers and metals to create unique patient specific and surgeon designed implants on demand across multiple fields of medicine.